Evidence map›Paper›PMID 22406825›Full record

ReviewCurrent opinion in hematology2012

Recent advances in vascular development.

Courtney K Domigan, M Luisa Iruela-Arispe

Abstract readReview
In one paragraph

Review in Current opinion in hematology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Molecular biomarkers in cardiac hypertrophy.Journal of cellular and molecular medicine · 2019
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Courtney K DomiganDepartment of Molecular, Cell and Developmental Biology and Molecular Biology Institute, University of California, Los Angeles, California, USA.
M Luisa Iruela-Arispe
Molecular Oncology (United States) · USUniversity of California, Los Angeles · US

Funding

Vascular Biology Training GrantT32HL069766 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LUSIS, ALDONS JAKE · 2002 to 2022
$7.4M
Notch Signaling in Vascular Development and HomeostasisR01HL085618 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI IRUELA-ARISPE, M. LUISA · 2007 to 2011
$1.9M
VEGF Signaling and Tumor MicroenvironmentR01CA126935 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI IRUELA-ARISPE, M. LUISA · 2007 to 2011
$1.4M
NCI NIH HHS R01 CA126935NCI NIH HHS R01CA126935NHLBI NIH HHS R01 HL085618NHLBI NIH HHS R01HL08618NHLBI NIH HHS T32 HL069766NHLBI NIH HHS T32 HL69766
6 · The paper itself

Abstract

purpose of reviewThis review offers a concise summary of the most recent experimental advances in vascular development using the mouse as a model organism. RECENT

findingsRecent mouse studies have revealed a spread of phenotypic diversity between endothelia of distinct developmental origins and organs. For example, expression of unique transcription factors distinguishes hemogenic from nonhemogenic endothelium within the same vessel. Vasculature of the brain is particularly susceptible to endothelial malformations due to combinatorial germline and somatic mutations; surprisingly these mutations can afflict the endothelium by either cell autonomous or paracrine effects. Mutant mice have been used to understand how multiple signaling pathways integrate and refine cellular responses. In particular, we learned how VEGFR3 regulates Notch signaling and EphrinB2 coordinates VEGFR2 responses. The regulation of Prox1 by miR181 highlighted the contribution of microRNAs in the induction of lymphatic endothelium. Information gained on heterotypic interactions has further clarified the influence of blood vessels on the morphogenesis of parenchyma and contributed to our understanding of organ-specific endothelial differentiation. Finally, mouse models have uncovered endothelial cell polarity as a keystone for successful vascular lumenization. SUMMARY: Our understanding of the process of vascular development has gained significant refinement in the last two years and has clarified the origin of several disorders rooted in development.

Indexed as

Models, AnimalAnimalsBlood VesselsCell CommunicationCell DifferentiationEndothelium, VascularHematopoiesisIntercellular Signaling Peptides and ProteinsMembrane ProteinsMiceReceptors, NotchSignal TransductionVascular DiseasesIntercellular Signaling Peptides and ProteinsMembrane ProteinsReceptors, Notch

Identifiers

PMID22406825
PMCPMC3666551
OpenAlexW2084843848

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.